MDEV — First Trust Indxx Medical Devices ETF
Data updated: 2026-08-21
MDEV — First Trust Indxx Medical Devices ETF. Global (incl. US) Mid Cap Blend / Core Health Care Equity. Holdings, fees, performance and SEC filings.
MDEV Fund Overview
MDEV — First Trust Indxx Medical Devices ETF is a US ETF managed by First Trust Exchange-Traded Fund VI, categorised as Global (incl. US) Mid Cap Blend / Core Health Care Equity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US ETF
- Manager: First Trust Exchange-Traded Fund VI
- Category: Global (incl. US) Mid Cap Blend / Core Health Care Equity
- Assets under management: $1.92M
- 1-year return: -6.7%
- Ticker: MDEV
- SEC CIK: 0001552740
- SEC series ID: S000071976
- Share class ID: C000227613
MDEV Holdings
Top 10 holdings of First Trust Indxx Medical Devices ETF by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| West Pharmaceutical Services, Inc. | 2.86% |
| Demant A/s | 2.70% |
| Livanova PLC | 2.69% |
| Baxter International, Inc. | 2.55% |
| Revvity, Inc. | 2.54% |
| Straumann Holding AG | 2.53% |
| Wuxi Apptec Co. Ltd. | 2.44% |
| Waters Corp. | 2.40% |
| Edwards Lifesciences Corp. | 2.38% |
| Agilent Technologies, Inc. | 2.37% |
MDEV Portfolio Allocation
Asset-class allocation of First Trust Indxx Medical Devices ETF by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 99.5% |
| Cash & Equivalents | 0.5% |
MDEV Performance
Total returns for MDEV (as of 2026-09-01), from SEC filings.
| Period | Total return |
|---|---|
| YTD | -8.7% |
| 1 year | -6.7% |
| 3 years (annualised) | -2.9% |
| 5 years (annualised) | -5.4% |
MDEV Risk Information
Risk metrics for MDEV, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 12.8%
MDEV Costs and Fees
MDEV costs about $70 per $10,000 invested per year in fund expenses.
- Net expense ratio: 0.70%
- Gross expense ratio: 0.70%
- Portfolio turnover: 20%
- Brokerage commissions: 0.86 bps of average net assets (SEC N-CEN)
MDEV Cashflows
Over the 12 months to 2026-06, First Trust Indxx Medical Devices ETF had net inflows of $0, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2026-06 | $0 |
| 2026-05 | $0 |
| 2026-04 | $0 |
| 2026-03 | $0 |
| 2026-02 | $0 |
| 2026-01 | $0 |
MDEV Debt Constituents
No individual debt constituents are reported in First Trust Indxx Medical Devices ETF's latest SEC N-PORT filing.
MDEV Prospectus and SEC Filings
Official First Trust Indxx Medical Devices ETF filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
- Prospectus (485BPOS) — filed 2026-07-29
- Prospectus (485BPOS) — filed 2025-07-29
- Prospectus (485BPOS) — filed 2024-07-29
- Portfolio holdings (N-PORT) — filed 2026-08-21
- Portfolio holdings (N-PORT) — filed 2026-05-21
- Portfolio holdings (N-PORT) — filed 2026-02-25
- Annual census (N-CEN) — filed 2026-06-10
- Annual census (N-CEN) — filed 2025-06-12
Related Funds
Other Global (incl. US) Mid Cap Blend / Core Health Care Equity funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.